You are using an older browser version. Please use a supported version for the best MSN experience.

CF patients await access to ‘game-changing’ drug Trikafta as it moves closer to approval

Cystic fibrosis (CF) affects 43-hundred people in Canada, including 130 in Saskatchewan. Most of them don't have access to any life-changing gene modifier drugs/medications that are available in other countries. Many CF patients are hopeful a drug called Trikafta moves closer to being approved in Canada. MANY CF PATIENTS ARE REMAINING OPTIMISTIC AS THE DRUG TRIKAFTA INCHES ITS WAY CLOSER TO BE APPROVED IN CANADA.
image beaconimage beaconimage beacon